Literature DB >> 24295938

Decade of 'normal' mammography reports--the happygram.

Nancy M Cappello1.   

Abstract

Interest in breast density reporting legislation has accelerated in the past several years, driven primarily by patients turned advocates under the mentorship and leadership of Are You Dense, Inc, and Are You Dense Advocacy, Inc. The history of the density reporting movement and the birth of education and advocacy nonprofits are described, along with how legislative efforts began. The decades of scientific research on dense tissue's masking effect and its being established as an independent risk factor for breast cancer are summarized. Finally, the opposition's arguments against density reporting legislation are addressed.
Copyright © 2013 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer screening; dense breast tissue; interval breast cancer; legislation; patient advocacy; public policy

Mesh:

Year:  2013        PMID: 24295938     DOI: 10.1016/j.jacr.2013.09.006

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  10 in total

Review 1.  Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts.

Authors:  John R Scheel; Janie M Lee; Brian L Sprague; Christoph I Lee; Constance D Lehman
Journal:  Am J Obstet Gynecol       Date:  2014-06-21       Impact factor: 8.661

2.  The Divide Between Breast Density Notification Laws and Evidence-Based Guidelines for Breast Cancer Screening: Legislating Practice.

Authors:  Jennifer S Haas; Celia P Kaplan
Journal:  JAMA Intern Med       Date:  2015-09       Impact factor: 21.873

Review 3.  Intensified surveillance for early detection of breast cancer in high-risk patients.

Authors:  Ulrich Bick
Journal:  Breast Care (Basel)       Date:  2015-02       Impact factor: 2.860

4.  Dense breast tissue notification: impact on women's perceived risk, anxiety, and intentions for future breast cancer screening.

Authors:  Vivian M Yeh; Julie B Schnur; Laurie Margolies; Guy H Montgomery
Journal:  J Am Coll Radiol       Date:  2014-11-04       Impact factor: 5.532

5.  Supplemental Breast Imaging Utilization After Breast Density Legislation in North Carolina.

Authors:  Sarah J Nyante; Mary W Marsh; Thad Benefield; Kathryn Earnhardt; Sheila S Lee; Louise M Henderson
Journal:  J Am Coll Radiol       Date:  2019-07-01       Impact factor: 5.532

6.  A letter is not enough: Women's preferences for and experiences of receiving breast density information.

Authors:  Nancy R Kressin; Jolie B Wormwood; Tracy A Battaglia; Priscilla J Slanetz; Christine M Gunn
Journal:  Patient Educ Couns       Date:  2022-03-19

7.  Primary Care Provider Experience with Breast Density Legislation in Massachusetts.

Authors:  Christine M Gunn; Nancy R Kressin; Kristina Cooper; Cinthya Marturano; Karen M Freund; Tracy A Battaglia
Journal:  J Womens Health (Larchmt)       Date:  2018-01-17       Impact factor: 2.681

8.  Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of "Informed".

Authors:  Karen E Schifferdecker; Anna N A Tosteson; Celia Kaplan; Karla Kerlikowske; Diana S M Buist; Louise M Henderson; Dianne Johnson; Jill Jaworski; Gloria Jackson-Nefertiti; Kelly Ehrlich; Mary W Marsh; Lisa Vu; Tracy Onega; Karen J Wernli
Journal:  J Gen Intern Med       Date:  2019-12-02       Impact factor: 5.128

9.  The Impact of Breast Density Information or Notification on Women's Cognitive, Psychological, and Behavioral Outcomes: A Systematic Review.

Authors:  Brooke Nickel; Tessa Copp; Meagan Brennan; Rachel Farber; Kirsten McCaffery; Nehmat Houssami
Journal:  J Natl Cancer Inst       Date:  2021-10-01       Impact factor: 13.506

10.  Breast cancer supplemental screening: Women's knowledge and utilization in the era of dense breast legislation.

Authors:  Jenerius A Aminawung; Jessica R Hoag; Kelly A Kyanko; Xiao Xu; Ilana B Richman; Susan H Busch; Cary P Gross
Journal:  Cancer Med       Date:  2020-06-14       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.